Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    UNIS logo
    Abbott Rapid Diagnostics logo depicts a white stylized infinity symbol representing continuous testing and reliable results

    Abbott Rapid Dx North America Llc

    Abbott Rapid Dx North America LLC delivers advanced rapid diagnostic solutions, specializing in point-of-care and in vitro diagnostics for healthcare providers across North America.

    Company Overview

    Abbott Rapid Dx North America LLC, a subsidiary of Abbott Laboratories, operates in the medical diagnostics industry, focusing on rapid and point-of-care testing solutions. The company manufactures and distributes in vitro diagnostic products, including rapid antigen and molecular tests, serving hospitals, clinics, and government agencies. With a strong presence in the U.S. healthcare market, it plays a critical role in public health and disease management.

    Key Metrics

    350

    Import Shipments

    4

    Distribution Centers

    25.0M

    Annual Revenue

    2007

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Abbott Rapid Dx North America LLC has recently focused on expanding its rapid diagnostic portfolio, enhancing manufacturing capacity, and supporting public health responses to infectious disease outbreaks.

    Strategic Expansion

    Introduction of next-generation rapid antigen and molecular diagnostic tests for emerging pathogens

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Abbott Rapid Dx North America LLC is a leading provider of rapid diagnostic products, including COVID-19 antigen tests, in vitro diagnostics, and molecular diagnostic platforms. The company supports healthcare providers with innovative point-of-care solutions that enable fast, accurate clinical decisions. As part of Abbott’s global diagnostics division, it leverages advanced technology and a robust distribution network to serve diverse healthcare settings. Its products are widely used in hospitals, clinics, laboratories, and government health programs.

    Headquarters

    Orlando, FL, United States

    Founded

    2007

    Stock Symbol

    Private company